NIH suspends production in two facilities, Outside QA companies called in

In light of serious problems identified in the NIH Clinical Center Pharmaceutical Development Section last year, NIH launched a multifaceted effort to ensure that processes for patient safety and quality of care at the hospital are of the highest standards. Accordingly, NIH hired two companies specializing in quality assurance for manufacturing and compounding - Working ["]